Inpharma Weekly

, Volume 881, Issue 1, pp 6–6 | Cite as

Nilutamide - compliance attractive in prostate cancer

Newsletter Article

Keywords

Prostate Cancer Testosterone Androgen Androgen Receptor Objective Response Rate 

Copyright information

© Adis International Ltd 1993

Personalised recommendations